{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:26:55Z","timestamp":1790681215246,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Primary angiitis of the central nervous system (PACNS) is a severe inflammatory disease, and soluble triggering receptor expressed on myeloid cells 2 (sTREM2) has been reported to be associated with inflammation of the CNS. However, the role of sTREM2 in PACNS remains unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We obtained serum and cerebrospinal fluid (CSF) samples from 18 patients diagnosed with PACNS, as well as 14 patients diagnosed with other neurological disorders with no evidence of inflammation. sTREM2 concentrations in the samples were detected by enzyme-linked immunosorbent assay. And routine CSF measurements of PACNS patients were analysed, including number of White Blood Cells (WBC), protein, Immunoglobulin G (IgG) index and CSF\/serum quotients. Levels of inflammatory cytokines, including tumor necrosis factor-\u03b1, interleukin (IL)-6, IL-8, IL-1\u03b2, and complement C4, also were tested. The modified Rankin scale (mRS), National Institutes of Health Stroke Scale (NIHSS), and activities of daily living (ADL) scores were obtained as indicators of disease severity. In PACNS patients, cerebral lesion volume was evaluated by magnetic resonance imaging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>sTREM2 levels in serum and CSF were significantly elevated in PACNS patients and significantly associated with the mRS, NIHSS and ADL scores as well as inflammatory cytokine levels. Additionally, positive correlations were observed between the cerebral lesion volume and the sTREM2 levels in both blood and CSF. Higher sTREM2 levels in either the blood or CSF seemed to predict a good prognosis in PACNS patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results indicate an association between serum and CSF sTREM2 levels and the severity of neurological damage. Thus, sTREM2 represents a potential biomarker for monitoring disease and potentially predicting the prognosis of PACNS patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.963373","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T10:09:06Z","timestamp":1672135746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Soluble TREM2 is a potential biomarker for the severity of primary angiitis of the CNS"],"prefix":"10.3389","volume":"13","author":[{"given":"Tianshu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengri","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoxi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunting","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.4.852","article-title":"A novel antineuronal antibody in a motor neuron syndrome associated with breast cancer","volume":"53","author":"Ferracci","year":"1999","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04662-4","article-title":"Initial experience with [18F]DPA-714 TSPO-PET to image inflammation in primary angiitis of the central nervous system","volume":"47","author":"Backhaus","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.007","article-title":"Diagnosis and classification of central nervous system vasculitis","author":"Hajj-Ali","year":"2014","journal-title":"J Autoimmun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000738","article-title":"An update of the Mayo clinic cohort of patients with adult primary central nervous system vasculitis: Description of 163 patients","volume":"94","author":"Salvarani","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.08.004","article-title":"Primary angiitis of the central nervous system","volume":"12","author":"Hajj-Ali","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1046\/j.0004-8461.2003.01140.x","article-title":"Primary angiitis of the central nervous system: MRI features and clinical presentation","volume":"47","author":"Singh","year":"2003","journal-title":"Australas Radiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2014.12.004","article-title":"Primary angiitis of the central nervous system. diagnostic criteria","volume":"33","author":"Powers","year":"2015","journal-title":"Neurol Clin"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09285-1","article-title":"Relapse rates and long-term outcome in primary angiitis of the central nervous system","author":"Schuster","year":"2019","journal-title":"J Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70243-X","article-title":"Treatment of small vessel primary CNS vasculitis in children: An open-label cohort study","volume":"9","author":"Hutchinson","year":"2010","journal-title":"Lancet Neurol"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.007","article-title":"Study on the clinical, imaging, and pathological characteristics of 18 cases with primary central nervous system vasculitis","volume":"28","author":"Wang","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007850","article-title":"Exploratory proteomic analysis implicates the alternative complement cascade in primary CNS vasculitis","volume":"93","author":"Mandel-Brehm","year":"2019","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s001090050101","article-title":"Role of macrophages\/microglia in multiple sclerosis and experimental allergic encephalomyelitis","volume":"75","author":"Benveniste","year":"1997","journal-title":"J Mol Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.11.032","article-title":"Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis","volume":"184","author":"Neumann","year":"2007","journal-title":"J Neuroimmunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"105630","DOI":"10.1016\/j.nbd.2022.105630","article-title":"Soluble TREM2: Innocent bystander or active player in neurological diseases","volume":"165","author":"Filipello","year":"2022","journal-title":"Neurobiol Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF02116277","article-title":"Synthesis of complement by macrophages and modulation of their functions through complement activation","volume":"6","author":"Hartung","year":"1983","journal-title":"Springer Semin Immunopathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.6.3520","article-title":"Cutting edge: TREM-2 attenuates macrophage activation","volume":"177","author":"Turnbull","year":"2006","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00062","article-title":"Increased CSF soluble TREM2 concentration in patients with neurosyphilis","volume":"11","author":"Li","year":"2020","journal-title":"Front Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515624558","article-title":"Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone","volume":"22","author":"\u00d6hrfelt","year":"2016","journal-title":"Mult Scler"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.176.4.1761016","article-title":"Imaging cerebral vasculitis in refractory epilepsy using [11C](R)-PK11195 positron emission tomography","volume":"176","author":"Goerres","year":"2001","journal-title":"Am J Roentgenol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.02.003","article-title":"Structure, expression pattern and biological activity of molecular complex TREM-2\/DAP12","volume":"74","author":"Paradowska-Gorycka","year":"2013","journal-title":"Hum Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141679","article-title":"TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR","volume":"42","author":"Ito","year":"2012","journal-title":"Eur J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain"},{"key":"B23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/biom12020222","article-title":"Neuroinflammation is associated with GFAP and sTREM2 levels in multiple sclerosis","volume":"12","author":"Azzolini","year":"2022","journal-title":"Biomolecules"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00136.2018","article-title":"Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke","volume":"316","author":"Yang","year":"2019","journal-title":"Am J Physiol - Cell Physiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636837","article-title":"Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis","volume":"37","author":"Piccio","year":"2007","journal-title":"Eur J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-10-80","article-title":"Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels","volume":"10","author":"Li","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/1469-8986.00016","article-title":"Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics","volume":"21","author":"Reiber","year":"2003","journal-title":"Restor Neurol Neurosci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci Transl Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.06.005","article-title":"Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early alzheimer\u2019s disease","volume":"12","author":"Gispert","year":"2016","journal-title":"Alzheimer\u2019s Dement"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.05.001","article-title":"Insights into TREM2 biology by network analysis of human brain gene expression data","volume":"34","author":"Forabosco","year":"2013","journal-title":"Neurobiol Aging"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.963373\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T10:09:10Z","timestamp":1672135750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.963373\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2022.963373"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.963373","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,27]]},"article-number":"963373"}}